Form 4 for IVDA Iveda Solutions, Inc.
Accepted 2021-09-27 00:00:00 ET · period of report 2021-09-23 · accession 0001493152-21-023785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-27 | 2017-08-16+ | IVDA | Berg Luz | CMO, General Manager | M - OptEx | $0.1169 | +1.24M | 425.7K | New | +$145.2K |
| DM | 2021-09-27 | 2017-12-29+ | IVDA | Berg Luz | CMO, General Manager | A - Grant | $0.00 | +1.02M | 150.0K | New | $0 |
| DM | 2021-09-27 | 2020-12-07 | IVDA | Berg Luz | CMO, General Manager | M - OptEx | $0.00 | -350.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2020-12-07 | M | A | 350,000 | $0.16 | 350,000 | D | — | — | (F1) Common stock was acquired from exercise of options and warrants. |
| 2 | Common | Common Stock | 2017-12-07 | M | A | 226,140 | $0.1 | 226,140 | D | — | — | (F1) Common stock was acquired from exercise of options and warrants. |
| 3 | Common | Common Stock | 2017-08-16 | M | A | 240,331 | $0.1 | 240,331 | D | — | — | (F1) Common stock was acquired from exercise of options and warrants. |
| 4 | Common | Common Stock | 2017-11-01 | M | A | 425,712 | $0.1 | 425,712 | D | — | — | (F1) Common stock was acquired from exercise of options and warrants. |
| 5 | Derivative | Options (Right to Buy) | 2020-12-15 | A | A | 700,000 | $0.00 | 700,000 | D | $0.37 · 2020-12-15 to 2030-12-15 | 700,000 Common Stock | (F2) The options subject to these grants vested 100% on the date of the grant. |
| 6 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 150,000 | $0.00 | 0 | D | $0.16 · 2019-12-20 to 2029-12-20 | 150,000 Common Stock | |
| 7 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 150,000 | $0.00 | 0 | D | $0.16 · 2018-12-28 to 2028-12-28 | 150,000 Common Stock | |
| 8 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 25,000 | $0.00 | 0 | D | $0.16 · 2017-12-19 to 2027-12-19 | 25,000 Common Stock | |
| 9 | Derivative | Options (Right to Buy) | 2020-12-07 | M | D | 25,000 | $0.00 | 0 | D | $0.16 · 2016-12-29 to 2026-12-29 | 25,000 Common Stock | |
| 10 | Derivative | Options (Right to Buy) | 2017-12-29 | A | A | 25,000 | $0.00 | 25,000 | D | $0.1 · 2017-12-29 to 2027-12-29 | 25,000 Common Stock | (F2) The options subject to these grants vested 100% on the date of the grant. |
| 11 | Derivative | Options (Right to Buy) | 2018-12-28 | A | A | 150,000 | $0.00 | 150,000 | D | $0.04 · 2018-12-28 to 2028-12-28 | 150,000 Common Stock | (F2) The options subject to these grants vested 100% on the date of the grant. |
| 12 | Derivative | Options (Right to Buy) | 2019-12-20 | A | A | 150,000 | $0.00 | 150,000 | D | $0.28 · 2019-12-20 to 2029-12-20 | 150,000 Common Stock | (F2) The options subject to these grants vested 100% on the date of the grant. |